US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist
  • 10.090
  • +0.110+1.10%
Close Nov 27 16:00 ET
  • 10.090
  • 0.0000.00%
Post 16:00 ET
495.24MMarket Cap-2826P/E (TTM)

KalVista Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
(Q2)Oct 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
51.98%44.22M
38.81%131.99M
150.91%40M
23.03%33.15M
14.92%29.75M
10.55%29.09M
16.94%95.09M
38.54%15.94M
0.98%26.95M
9.66%25.88M
Selling and administrative expenses
79.86%17.6M
77.41%54.28M
198.41%23.21M
54.43%10.63M
36.52%10.66M
20.37%9.79M
15.69%30.6M
2.36%7.78M
-0.91%6.88M
28.88%7.81M
-General and administrative expense
79.86%17.6M
77.41%54.28M
198.41%23.21M
54.43%10.63M
36.52%10.66M
20.37%9.79M
15.69%30.6M
2.36%7.78M
-0.91%6.88M
28.88%7.81M
Research and development costs
37.85%26.61M
7.34%86.17M
5.42%25.25M
12.26%22.52M
5.60%19.09M
6.16%19.31M
14.41%80.28M
24.66%23.95M
1.65%20.06M
3.03%18.08M
Other taxes
----
46.46%-8.45M
----
----
----
----
-3.15%-15.79M
----
----
----
Operating profit
-51.98%-44.22M
-38.81%-131.99M
-150.91%-40M
-23.03%-33.15M
-14.92%-29.75M
-10.55%-29.09M
-16.94%-95.09M
-38.54%-15.94M
-0.98%-26.95M
-9.66%-25.88M
Net non-operating interest income expense
83.32%1.69M
74.55%3.9M
87.25%1.51M
-6.56%684K
72.83%776K
281.40%923K
104.77%2.23M
201.49%808K
183.72%732K
54.83%449K
Non-operating interest income
83.32%1.69M
74.55%3.9M
87.25%1.51M
-6.56%684K
72.83%776K
281.40%923K
104.77%2.23M
201.49%808K
183.72%732K
54.83%449K
Other net income (expense)
-27.09%2.08M
2,841.51%1.45M
44.86%-6.16M
-29.96%3.44M
-58.45%1.32M
-5.90%2.85M
97.50%-53K
13.23%-11.17M
24.05%4.91M
-13.27%3.18M
Gain on sale of security
12.72%514K
3,085.71%1.46M
530.85%1.19M
87.60%1.12M
-309.78%-1.3M
188.20%456K
97.69%-49K
111.83%188K
401.52%597K
-13.21%-317K
Other non- operating income (expenses)
-34.67%1.57M
-150.00%-10K
35.33%-7.35M
-46.23%2.32M
-25.04%2.62M
-32.46%2.4M
-300.00%-4K
-0.66%-11.36M
3.78%4.31M
-11.39%3.49M
Income before tax
-59.75%-40.44M
-36.31%-126.64M
-69.74%-44.65M
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
Income tax
0
0
Net income
-59.75%-40.44M
-36.31%-126.64M
-69.74%-44.65M
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
Net income continuous Operations
-59.75%-40.44M
-36.31%-126.64M
-69.74%-44.65M
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
Minority interest income
Net income attributable to the parent company
-59.75%-40.44M
-36.31%-126.64M
-69.74%-44.65M
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-59.75%-40.44M
-36.31%-126.64M
-69.74%-44.65M
-36.26%-29.03M
-24.23%-27.65M
-9.87%-25.32M
-12.83%-92.91M
-9.09%-26.31M
5.18%-21.3M
-13.27%-22.26M
Basic earnings per share
-17.57%-0.87
-3.30%-3.44
-38.96%-1.07
-12.00%-0.84
11.11%-0.8
21.28%-0.74
0.89%-3.33
21.43%-0.77
18.48%-0.75
-12.50%-0.9
Diluted earnings per share
-17.57%-0.87
-3.30%-3.44
-38.96%-1.07
-12.00%-0.84
11.11%-0.8
21.28%-0.74
0.89%-3.33
21.43%-0.77
18.48%-0.75
-12.50%-0.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023(Q2)Oct 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 51.98%44.22M38.81%131.99M150.91%40M23.03%33.15M14.92%29.75M10.55%29.09M16.94%95.09M38.54%15.94M0.98%26.95M9.66%25.88M
Selling and administrative expenses 79.86%17.6M77.41%54.28M198.41%23.21M54.43%10.63M36.52%10.66M20.37%9.79M15.69%30.6M2.36%7.78M-0.91%6.88M28.88%7.81M
-General and administrative expense 79.86%17.6M77.41%54.28M198.41%23.21M54.43%10.63M36.52%10.66M20.37%9.79M15.69%30.6M2.36%7.78M-0.91%6.88M28.88%7.81M
Research and development costs 37.85%26.61M7.34%86.17M5.42%25.25M12.26%22.52M5.60%19.09M6.16%19.31M14.41%80.28M24.66%23.95M1.65%20.06M3.03%18.08M
Other taxes ----46.46%-8.45M-----------------3.15%-15.79M------------
Operating profit -51.98%-44.22M-38.81%-131.99M-150.91%-40M-23.03%-33.15M-14.92%-29.75M-10.55%-29.09M-16.94%-95.09M-38.54%-15.94M-0.98%-26.95M-9.66%-25.88M
Net non-operating interest income expense 83.32%1.69M74.55%3.9M87.25%1.51M-6.56%684K72.83%776K281.40%923K104.77%2.23M201.49%808K183.72%732K54.83%449K
Non-operating interest income 83.32%1.69M74.55%3.9M87.25%1.51M-6.56%684K72.83%776K281.40%923K104.77%2.23M201.49%808K183.72%732K54.83%449K
Other net income (expense) -27.09%2.08M2,841.51%1.45M44.86%-6.16M-29.96%3.44M-58.45%1.32M-5.90%2.85M97.50%-53K13.23%-11.17M24.05%4.91M-13.27%3.18M
Gain on sale of security 12.72%514K3,085.71%1.46M530.85%1.19M87.60%1.12M-309.78%-1.3M188.20%456K97.69%-49K111.83%188K401.52%597K-13.21%-317K
Other non- operating income (expenses) -34.67%1.57M-150.00%-10K35.33%-7.35M-46.23%2.32M-25.04%2.62M-32.46%2.4M-300.00%-4K-0.66%-11.36M3.78%4.31M-11.39%3.49M
Income before tax -59.75%-40.44M-36.31%-126.64M-69.74%-44.65M-36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M
Income tax 00
Net income -59.75%-40.44M-36.31%-126.64M-69.74%-44.65M-36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M
Net income continuous Operations -59.75%-40.44M-36.31%-126.64M-69.74%-44.65M-36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M
Minority interest income
Net income attributable to the parent company -59.75%-40.44M-36.31%-126.64M-69.74%-44.65M-36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -59.75%-40.44M-36.31%-126.64M-69.74%-44.65M-36.26%-29.03M-24.23%-27.65M-9.87%-25.32M-12.83%-92.91M-9.09%-26.31M5.18%-21.3M-13.27%-22.26M
Basic earnings per share -17.57%-0.87-3.30%-3.44-38.96%-1.07-12.00%-0.8411.11%-0.821.28%-0.740.89%-3.3321.43%-0.7718.48%-0.75-12.50%-0.9
Diluted earnings per share -17.57%-0.87-3.30%-3.44-38.96%-1.07-12.00%-0.8411.11%-0.821.28%-0.740.89%-3.3321.43%-0.7718.48%-0.75-12.50%-0.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data